Genmab A/S - Product Pipeline Review - 2016

1
Genmab A/S - Product Pipeline Review - 2016
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2
Report Overview
Genmab A/S - Product Pipeline Review - 2016,
provides an overview of the Genmab A/Ss
pharmaceutical research and development focus.
The report provides comprehensive information
on the therapeutics under development by Genmab
A/S, complete with analysis by stage of
development, drug target, mechanism of action
(MoA), route of administration (RoA) and molecule
type. The report also covers the descriptive
pharmacological action of the therapeutics, its
complete research and development history and the
dormant and discontinued projects. The report
helps in identifying and tracking emerging
players in the market and their portfolios,
enhances decision making capabilities and helps
to create effective counter strategies to gain
competitive advantage. Read More At
http//www.researchbeam.com/genmab-a-s-product-pip
eline-review-2016-market
3
Report Overview

• Scope
• The report provides a snapshot of the pipeline
  therapeutic landscape of Genmab A/S
• The report provides overview of Genmab A/S
  including its business description, key facts,
  and locations and subsidiaries
• The report covers pipeline products based on
  various stages of development ranging from
  pre-registration till discovery and undisclosed
  stages
• The report features Genmab A/Ss out-licensed and
  partnered product portfolio and summarizes its
  dormant and discontinued projects
• Reasons to buy
• Evaluate Genmab A/Ss strategic position with
  total access to detailed information on its
  product pipeline
• Gain strategically significant competitor
  information, analysis, and insights to formulate
  effective RD strategies
• Identify potential new clients or partners in the
  target demographic
• Plan mergers and acquisitions effectively by
  identifying key players and its most promising
  pipeline therapeutics
• Read More At http//www.researchbeam.com/genmab-a
  -s-product-pipeline-review-2016-market

4
Table of Content
List of Tables Genmab A/S, Key Information
5Genmab A/S, Key Facts 5Genmab A/S - Pipeline
by Indication, 2016 7Genmab A/S - Pipeline by
Stage of Development, 2016 9Genmab A/S -
Monotherapy Products in Pipeline, 2016 10Genmab
A/S - Partnered Products in Pipeline, 2016
11Genmab A/S - Out-Licensed Products in
Pipeline, 2016 13Genmab A/S - Phase II, 2016
15Genmab A/S - Phase I, 2016 16Genmab A/S -
Preclinical, 2016 17Genmab A/S - Pipeline by
Target, 2016 31Genmab A/S - Pipeline by Route of
Administration, 2016 32Genmab A/S - Pipeline by
Molecule Type, 2016 33Genmab A/S - Pipeline
Products by Mechanism of Action, 2016 34Genmab
A/S - Recent Pipeline Updates, 2016 35Genmab A/S
- Dormant Developmental Projects,2016 37Genmab
A/S - Discontinued Pipeline Products, 2016
38Genmab A/S, Subsidiaries 41 Enquire More At
http//www.researchbeam.com/genmab-a-s-product-pip
eline-review-2016-market/enquire-about-report
5

FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/genmab-a-s-product-pip
eline-review-2016-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com